A Shot in the Dark

Therapeutic Vaccine Research Toward a Functional Cure Shows Promise by Jeannie Wraight Until recently, therapeutic vaccines and immune-based therapies (IBTs) were all but shunned by the...

New Nukes, Old Nukes

Nuclear Waste How to get overwhelmed by the data on new nukes, old nukes & lots of different classes of ART at AIDS 2014 by Mariel...

Mighty Mouse

Mighty Mouse A humanized BLT mouse model creates a vital platform for drug discovery by Chael Needle In the early stages of drug discovery, many candidates that...

AMBER Study: Phase 3 Symtuza Results

At the 16th European AIDS Conference in Milan, Italy, on October 25, 2017, Janssen Pharmaceutica, NV announced the results of its Phase 3 AMBER...

First Line

A treatment for advanced HIV-associated Kaposi’s sarcoma is relaunched by Chael Needle Newly acquired by Galen from Gilead Sciences, DaunoXome (daunorubicin citrate liposome injection) is an...

SMYD2 & the HIV Reservoir

Shock Value Research on SMYD2 shows potential to wake up the HIV reservoir by Chael Needle HIV latency—where HIV hides out in reservoirs, dormant and beyond the...

Bathroom Reading

A newly approved anti-diarrheal agent seeks to counter side effects of HAART by Chael Needle Recently, the FDA approved Fulyzaq (crofelemer) 125 mg delayed-release tablets for...

Cuts to Healthcare

Treatment Horizons by Chael Needle Hill & Mountain? Weakened federal support of HIV/AIDS services puts our health at risk President Obama’s fiscal year 2014 budget plan includes...

Optimal ARTs for Older Adults with HIV

Optimal ARTs for Older Adults with HIV Recently, the HIV-Age.org website published the results of a review to identify the most effective, least toxic ART...

AGS-004 Immunotherapy

Treatment Horizons by Chael Needle Fully Personalized An immunotherapy candidate stimulates T-cell responses via patient-specific antigens Previous studies have established immunotherapy candidate AGS-004, both as a single...

LATEST POSTS

$210M Funding Opportunity for CBOs

CDC Announces $210M Funding Opportunity for CBOs On September 28, 2020, the Centers for Disease Control and Prevention (CDC) announced the availability in fiscal 2021...

High Flight